SEC Form 4 · accession 0000930413-19-000103
ENZO BIOCHEM INC · ENZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory M. Bortz
Director
Period of report
Jan 14, 2019
Accepted (ET)
Jan 18, 2019 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000316253
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 14, 2019 | M | 9,184 | $2.70 | A | 93,699 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (to acquire common stock)F1 | $2.70 | Jan 14, 2019 | M | 64,286 | D | — | Jan 17, 2019 | Common Stock | 64,286 | 175,346 | D |
Explanation of responses
- F1Represents an exercise of options to acquire 64,286 shares of common stock, which, after the company withheld the exercise price for such options, resulted in a delivery of 9,184 shares to the reporting person.